These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 21947)
1. [Studies on beta-lactam antibiotics for medicinal purpose. IV. Stability of 6-[D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetamido)penicillanic acid (T-1220) in aqueous solution and body fluid (author's transl)]. Saikawa I; Takano S; Yoshida C; Saito E; Yasuda T Yakugaku Zasshi; 1977 Sep; 97(9):995-1001. PubMed ID: 21947 [No Abstract] [Full Text] [Related]
2. [Studies on beta-lactam antibiotics for medicinal purpose. V. Structure of degradation products of 6-[D(--)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetamido]penicillanic acid (T-1220) in aqueous solution (author's transl)]. Takano S; Yoshida C; Sakai H; Yamamoto Y; Tai M Yakugaku Zasshi; 1977 Oct; 97(10):1064-70. PubMed ID: 592098 [No Abstract] [Full Text] [Related]
3. [Studies on beta-lactam antibiotics for medicinal purpose. VII. Synthesis of 6-[D-alpha-(5 and 6-alkyl-4-ethyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetamido]-penicillanic acids and structure-antibacterial activity (author's transl)]. Takano S; Ochiai H; Nitta J; Komatsu M; Taki H; Tai M; Yasuda T; Saikawa I Yakugaku Zasshi; 1979 Apr; 99(4):371-9. PubMed ID: 225465 [No Abstract] [Full Text] [Related]
4. [Studies on beta-lactam antibiotics for medicinal purpose. VI. Studies on the metabolism of 6-[D(--)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-phenylacetamido]penicillanic acid (T-1220) (author's transl)]. Saikawa I; Takai A; Nakashima Y; Yoshida C; Yasuda T Yakugaku Zasshi; 1977 Oct; 97(10):1071-81. PubMed ID: 412944 [No Abstract] [Full Text] [Related]
5. [Studies on beta-lactam antibiotics for medicinal purpose. X. Stability and degradation pattern of sodium 7-[D(--)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)acetamido]-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]-3-cephem-4-carboxylate (T-1551) in aqueous solution (author's transl)]. Saikawa I; Momonoi K; Sakai H; Takashita Y; Ohashi T; Minami H; Yamamoto Y; Fukuoka Y Yakugaku Zasshi; 1979 Dec; 99(12):1207-18. PubMed ID: 544761 [No Abstract] [Full Text] [Related]
6. [Studies on beta-lactam antibiotics for medicinal purpose. III. Structure-activity relationship of 6-[D(-)-alpha-(4-alkyl-2,3-dioxo-1-piperazinecarbox-amido)phenylacetamido]penicillanic acids (author's transl)]. Saikawa I; Yasuda T; Taki H; Tai M; Watanabe Y Yakugaku Zasshi; 1977 Sep; 97(9):987-94. PubMed ID: 200728 [No Abstract] [Full Text] [Related]
7. [Studies on beta-lactam antibiotics for medicinal purpose. XIV. Stability and degradation pattern of sodium 7 beta-[(2R, 3S)-2-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-3-hydroxybutanamido]-7 alpha-methoxy-3-[(1-methyl-1H-tetrazol-5-yl)thiomethyl]-3-cephem-4- carboxylate (T-1982) in aqueous solution]. Takano S; Tai M; Sakai H; Takakura I; Ochiai H; Sugimoto Y; Fukuoka Y; Saikawa I Yakugaku Zasshi; 1983 Jan; 103(1):62-72. PubMed ID: 6864450 [No Abstract] [Full Text] [Related]
8. [Studies on beta-lactam antibiotics for medicinal purpose. VIII. Synthesis of 7-[D(-)-alpha-(4-alkyl-2,3-dioxo-1-piperazinecarboxamido)phenylacetamido]-cephalosporanic acids and structure-antibacterial activity (author's transl)]. Saikawa I; Takano S; Momonoi K; Takakura I; Kutani C; Ochiai H; Yoshida C; Yasuda T; Taki H Yakugaku Zasshi; 1979 Sep; 99(9):929-35. PubMed ID: 547056 [No Abstract] [Full Text] [Related]
9. [Studies on beta-lactam antibiotics for medicinal purpose. XI. Studies on the metabolism of sodium 7-(D(-)-alpha-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-alpha-(4-hydroxyphenyl)acetamido)-3-((1-methyl-1H-tetrazole-5-yl)thiomethyl)-3-cephem-4-carboxylate (T-1551) (author's transl)]. Saikawa I; Nakashima Y; Sakai H; Momonoi K; Ikegami T; Minami H; Hayakawa H; Ochiai H; Todo Y Yakugaku Zasshi; 1980 Jun; 100(6):625-40. PubMed ID: 6450829 [No Abstract] [Full Text] [Related]
10. [Absorption, excretion and distribution of 14C-labelled 6-[D(-)-alpha-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-alpha-phenylacetamido] penicillanic acid (14C-T-1220) in rats and mice (author's transl)]. Saikawa I; Takai A; Nakajima Y; Yasuda T; Shimizu E Jpn J Antibiot; 1977 Aug; 30(8):571-81. PubMed ID: 909145 [No Abstract] [Full Text] [Related]
11. [Pharmacological studies on a new penicillin group antibiotic, sodium 6-[D(-)-alpha-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-alpha-phenylacetamido] penicillanate (T-1220). II. Effect on circulatory system and blood (author's transl)]. Takai A; Hirai S; Hiraiwa T; Watanabe I; Omori M Jpn J Antibiot; 1977 Aug; 30(8):543-56. PubMed ID: 909143 [No Abstract] [Full Text] [Related]
12. [Studies on beta-lactam antibiotics for medicinal purpose. II. Synthesis of D(-)-alpha-[dioxo-1-piperazinecarboxamido]benzylpenicillins and structure-antibacterial activity (author's transl)]. Saikawa I; Takano S; Yoshida C; Takashima O; Momonoi K Yakugaku Zasshi; 1977 Sep; 97(9):980-6. PubMed ID: 243535 [No Abstract] [Full Text] [Related]
13. [Pharmacological studies on a new penicillin group antibiotic, sodium 6-[D(-)-alpha-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-alpha-phenylacetamido] penicillanate (T-1220). I. Effect on central and peripheral nervous systems (author's transl)]. Takai A; Hirai S; Watanabe I; Hiraiwa T; Abe N Jpn J Antibiot; 1977 Aug; 30(8):529-42. PubMed ID: 909142 [No Abstract] [Full Text] [Related]
14. [Pharmacological studies on a new penicillin group antibiotic, sodium 6-[D(-)-alpha-(4-ethyl-2, 3-dioxo-1-piperazinecarboxamido)-alpha-phenylacetamido] penicillanate (T-1220). III. Effect on smooth-muscle organs (author's transl)]. Takai A; Hirai S; Watanabe I; Hiraiwa T; Omori M Jpn J Antibiot; 1977 Aug; 30(8):557-70. PubMed ID: 909144 [No Abstract] [Full Text] [Related]
15. [Studies on beta-lactam antibiotics. III. Synthesis of 6-[D(--)-alpha-(acylamino)-phenylacetamido]penicillanic acids and antibacterial activity (author's transl)]. Tobiki H; Yamada H; Nakatsuka I; Shimago K; Eda Y; Noguchi H; Komatsu T; Nakagome T Yakugaku Zasshi; 1980 Jan; 100(1):38-48. PubMed ID: 6900065 [No Abstract] [Full Text] [Related]
16. [Studies on beta-lactam antibiotics. V. Synthesis of 6-[D(-)-alpha-(acylamino)-4-hydroxyphenylacetamido]penicillanic acids and antibacterial activity (author's transl)]. Tobiki H; Yamada H; Tanno N; Shimago K; Eda Y; Noguchi H; Komatsu T; Nakagome T Yakugaku Zasshi; 1980 Feb; 100(2):133-9. PubMed ID: 6245204 [No Abstract] [Full Text] [Related]
17. [In vitro stability and biotransformation of 3'-hydroxy-2-[N-methyl-N-(1,1-dimethyl-2-phenethyl)amino] acetophenone (TVX 960) (author's transl)]. Dell HD; Donike M; Jacobi H; Kamp R Arzneimittelforschung; 1980; 30(7):1138-44. PubMed ID: 7191296 [No Abstract] [Full Text] [Related]
18. [Pharmacological study of beta-lactam antibiotics (15). Metabolism of sodium 7 beta-[(2R,3S)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-3- hydroxybutanamido]-7 alpha-methoxy-3- [1-methyl-1H-tetrazol-5-yl) thiomethyl]-3-cephem-4-carboxylate (T-1982)]. Saikawa I; Nakashima Y; Tai M; Sakai H; Takakura I; Ikegami T; Hayakawa H; Shugimoto Y; Yamafuji T; Miyaura T Yakugaku Zasshi; 1983 Apr; 103(4):414-25. PubMed ID: 6415264 [No Abstract] [Full Text] [Related]
19. [Pharmacokinetic studies on the penetration of azlocillin and mezlocillin into bone and tissue fluid (author's transl)]. Wittmann DH; Schassan HH; Seidel H Arzneimittelforschung; 1981; 31(7):1157-62. PubMed ID: 6456009 [TBL] [Abstract][Full Text] [Related]
20. [Studies on beta-lactam antibiotics for medicinal purpose. I. Synthesis of D(-)-alpha-[(monooxo)-1-piperazinecarboxamido]benzylpenicillins and structure--antibacterial activity (author's transl)]. Saikawa I; Takano S; Yoshida C; Takashima O; Momonoi K Yakugaku Zasshi; 1977 Aug; 97(8):883-9. PubMed ID: 243015 [No Abstract] [Full Text] [Related] [Next] [New Search]